QLY Biotech Group (QLY Biotech Group) COGS-to-Revenue : 0.00 (As of Feb. 2023)

View and export this data going back to 2021. Start your Free Trial

What is QLY Biotech Group COGS-to-Revenue?

QLY Biotech Group's Cost of Goods Sold for the three months ended in Feb. 2023 was $0.00 Mil. Its Revenue for the three months ended in Feb. 2023 was $0.00 Mil.

QLY Biotech Group's COGS to Revenue for the three months ended in Feb. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. QLY Biotech Group's Gross Margin % for the three months ended in Feb. 2023 was N/A%.

QLY Biotech Group COGS-to-Revenue Historical Data

The historical data trend for QLY Biotech Group's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QLY Biotech Group COGS-to-Revenue Chart

QLY Biotech Group Annual Data

Trend

Aug19

Aug20

Aug21

Aug22

COGS-to-Revenue

0.25

QLY Biotech Group Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23
COGS-to-Revenue	Get a 7-Day Free Trial												-	-	-	-	-

QLY Biotech Group COGS-to-Revenue Calculation

QLY Biotech Group's COGS to Revenue for the fiscal year that ended in Aug. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

QLY Biotech Group's COGS to Revenue for the quarter that ended in Feb. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

QLY Biotech Group (OTCPK:LQLY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

QLY Biotech Group's Gross Margin % for the three months ended in Feb. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

QLY Biotech Group COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of QLY Biotech Group's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

QLY Biotech Group (QLY Biotech Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » QLY Biotech Group Corp (OTCPK:LQLY) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

5348 Vegas Drive, Las Vegas, NV, USA, 89108

Website

QLY Biotech Group Corp is a United States based company engaged in the tourism business.

QLY Biotech Group (QLY Biotech Group) Headlines

No Headlines